Elsevier

Journal of Hepatology

Volume 24, Issue 2, February 1996, Pages 161-168
Journal of Hepatology

Plasma endothelin-1 and -3 in cirrhosis: relationship with systemic hemodynamics, renal function and neurohumoral systems

https://doi.org/10.1016/S0168-8278(96)80025-0Get rights and content

Abstract

Background/Aims: The postural change from upright to supine is a physiological maneuvre which increases central blood volume. This model was used to investigate the effects of changes in effective volemia on plasma endothelin-1 and -3 concentrations in cirrhosis.

Methods: Plasma endothelin concentrations, measured by radio-immunoassay, were determined in 20 patients with cirrhosis, 10 of whom had ascites, and nine healthy control subjects, in the upright posture and 30, 60 and 120 min after the assumption of the supine position.

Results: In the upright posture, endothelin-1 was 8.9±0.4 pg/ml and endothelin-3 3.7±0.6 (mean±SEM) pg/ml in control subjects. Endothelin-1 was increased only in patients with ascites (12.7±1.4 pg/ml, p<0.05; patients without ascites: 9.7±0.7 pg/ml), while endothelin-3 was elevated in both patients with and without ascites (8.0±1.5 pg/ml, p<0.01; 5.9±0.5 pg/ml, p=0.01, respectively). In the supine position, no significant changes in endothelin-1 or -3 occurred either in patients with ascites or in controls throughout the observation period, while a reduction in endothelin-3 was found in compensated patients after 30 and 60 min. In patients, we found negative correlations between endothelin-3, but not endothelin-1, and mean arterial pressure, both in upright (r=−0.59; p<0.01) and supine (r=−0.56; p=0.01) positions, atrial natriuretic factor (r=0.50; p<0.05) and plasma renin activity (r=0.67; p-0.001) in the supine position alone. In patients with ascites, endothelin-1 was inversely correlated with both glomerular filtration rate (upright: r=−0.62; p=0.06; supine: r=−0.71, p<0.05) and renal sodium excretion (upright: r=−0.82; p<0.01; supine: r=−0.88; p<0.001).

Conclusions: Plasma endothelin-1 and −3 were increased in cirrhosis with ascites, while, in pre-ascitic cirrhosis, only endothelin-3 was increased in the upright posture. Although increased endothelin-3 was associated with features suggesting a reduced effective volemia, it is likely that other mechanisms than hypovolemia were mainly responsible for high plasma endothelin levels. Increased endothelin production may play a role in circulatory and renal function abnormalities of advanced cirrhosis

References (45)

  • H Kaufmann et al.

    Plasma endothelin during upright tilt: relevance for orthostatic hypotension?

    Lancet

    (1991)
  • M.E Stark et al.

    Role of nitric oxide in gastrointestinai and hepatic function an disease

    Gastroenterology

    (1992)
  • M Sugiura et al.

    Endotoxin stimulates endothelin release in vivo and in vitro as determined by radioimmunoassay

    Biochem Biophys Res Commun

    (1989)
  • V Kon et al.

    Biological actions and pathophysiologic significance of endothelin in the kidney

    Kidney Int

    (1991)
  • T.F Lüscher et al.

    Endothelium-derived relaxing and contracting factors: perspectives in nephrology

    Kidney Int

    (1991)
  • K.L Skorecki et al.

    Body fluid homeostasis in congestive heart failure and cirrhosis with ascites

    Am J Med

    (1982)
  • W Jimenez et al.

    Pathogenesis of sodium retention in cirrhosis

    J Hepatol

    (1993)
  • M.S Simonson

    Endothelins: multifunctional renal peptides

    Physiol Rev

    (1993)
  • A Inoue et al.

    The human endothelin family: three structurally and pharmacologically distinct isopeptides predicted by three separated genes

    Proc Natl Acad Sci

    (1989)
  • W.G Haynes et al.

    The endothelin family of peptides: local hormones with diverse roles in health and disease?

    Clin Sci

    (1993)
  • GM Rubanyi et al.

    Endothelins

    FASEB J

    (1991)
  • T Masaki

    The discovery, the present state, and the future prospects of endothelin

    J Cardiovasc Pharmacol

    (1989)
  • Cited by (59)

    • Dysbalance in sympathetic neurotransmitter release and action in cirrhotic rats: Impact of exogenous neuropeptide y

      2013, Journal of Hepatology
      Citation Excerpt :

      Furthermore, dysbalanced SNS neurotransmitter release is in accordance with evidence of differential modulation of NA and NPY release in the rat mesenteric bed: endothelins (ET-1, ET-3) have been shown to inhibit NPY release but not NA release [33], closely resembling our results. Considering cirrhosis, circulating plasma levels of endothelin-1 and -3 are elevated [34,35] and therefore could contribute to selective inhibition of NPY release. Finally, the observed accelerated decline of PNS-induced NA release and dysregulated NA release in cirrhosis may reflect reduced expression of genes regulating axonal transport, vesicle trafficking, and exocytosis of catecholamines [11].

    • Portopulmonary hypertension: From diagnosis to treatment

      2011, European Journal of Internal Medicine
      Citation Excerpt :

      In addition, the presence of portosystemic shunts allows different vascular mediators to bypass liver metabolism creating an imbalance between vasoconstrictor and vasodilator factors at the level of pulmonary vasculature. Mediators such as endothelin-1, thromboxane A2, Vasoactive Intestinal Peptide (VIP), and serotonin can have direct vasoacitve and mitogenic effects and can cause damage to the pulmonary endothelium [6,19]. The imbalance is further augmented by a decrease in synthesis of vasodilators factors such as nitric oxide (NO) and prostacycline [20,21].

    • Portopulmonary hypertension: State of the art

      2008, Annals of Hepatology
      Citation Excerpt :

      A proposed mechanism for POPH includes the increased blood flow (high cardiac output) in chronic liver disease causing vascular wall shear stress, which can activate a cascade of events that may eventually lead to the characteristic vasculopathic changes in POPH, and that also could be present in any form of PAH.13 Increased levels of endothelin-1 (ET-1), a potent vasoconstrictor produced by the pulmonary vascular endothelium and the liver, has been shown to play a role in the pathogenesis of idiopathic PAH, as well as in other forms of PAH.14,15 The presence of portosystemic shunts may allow the shunting of the vasoactive substances from the splachnic circulation to the pulmonary circulation, allowing these vasoactive mediators to bypass the liver metabolism and causing substantial effects in the pulmonary vasculature.2-4

    • HEPATIC CIRRHOSIS

      2008, Pharmacology and Therapeutics: Principles to Practice
    View all citing articles on Scopus
    View full text